v3.25.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Condensed Consolidated Statements of Operations [Abstract]    
Revenue $ 2,170 $ 7,990
Operating expenses:    
Cost of revenues 154 213
Research and development (includes $11,099 and $10,532 of share-based compensation expense for the three months ended June 30, 2025 and 2024, respectively) 152,919 120,507
General and administrative (includes $71,079 and $36,841 of share-based compensation expense for the three months ended June 30, 2025 and 2024, respectively) 134,019 99,892
Total operating expenses 287,092 220,612
Gain on sale of Telavant net assets 0 110,387
Loss from operations (284,922) (102,235)
Change in fair value of investments 19,125 (15,226)
Change in fair value of liability instruments 2,329 1,150
Interest income (48,322) (72,127)
Other expense, net 11,208 3,608
Loss from continuing operations before income taxes (269,262) (19,640)
Income tax expense 4,649 11,963
Loss from continuing operations, net of tax (273,911) (31,603)
Income from discontinued operations, net of tax 0 89,093
Net (loss) income (273,911) 57,490
Net loss attributable to noncontrolling interests (50,556) (37,807)
Net (loss) income attributable to Roivant Sciences Ltd. (223,355) 95,297
Amounts attributable to Roivant Sciences Ltd.:    
(Loss) income from continuing operations, net of tax (223,355) 6,049
Income from discontinued operations, net of tax 0 89,248
Net (loss) income attributable to Roivant Sciences Ltd. $ (223,355) $ 95,297
Net (loss) income per common share, basic:    
(Loss) income from continuing operations, net of tax (in Dollars per share) $ (0.33) $ 0.01
Income from discontinued operations, net of tax (in Dollars per share) 0 0.12
Net (loss) income per common share (in Dollars per share) (0.33) 0.13
Net (loss) income per common share, diluted:    
(Loss) income from continuing operations, net of tax (in Dollars per share) (0.33) 0.01
Income from discontinued operations, net of tax (in Dollars per share) 0 0.11
Net (loss) income per common share (in Dollars per share) $ (0.33) $ 0.12
Weighted average shares outstanding:    
Basic (in Shares) 680,286,922 735,816,536
Diluted (in Shares) 680,286,922 781,627,601